Anxiety and depression are prominent in patients after percutaneous coronary interventions (PCI) for coronary artery disease (CAD), thus affecting patients'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. CAD patients with anxiety and depression after PCI; Hamilton Anxiety Rating Scale (HAMA) score at least7 points, and Hamilton Depression Rating Scale (HAMD) score at least14 points; 2.Aged 18 to 85; 3.No anti-anxiety or depression medication within the last 2 weeks; 4.Voluntarily accepted the random grouping and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with combined severe or unstable cardiac, cerebral, hepatic, renal, endocrine, hematological and other medical diseases; 2.Patients with progressive development or very poor prognosis, such as severe infections, severe water-electrolyte disorders, acid-base imbalance; 3. Patients with severe anxiety and depression, requiring oral anti-anxiety and depression drugs; 4. Patients with severe cognitive dysfunction who are unable to communicate; 5.Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Anxiety Scale (HAMA) 6 days The scale consists of 14 items, and each entry is scored on a scale of 0 to 3. The cumulative entry scores are summed to a total HAMA score, with a total score range of 0 to 42. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale (HAMD) 6 days We used a 17-item version for evaluation, with evaluation items including despair, anxiety, sleep disorders, weight, cognitive impairment, day and night change, and retardation. | — |
Countries
China
Contacts
The First People's Hospital of Lianyungang